ZA937315B - Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance - Google Patents
Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistanceInfo
- Publication number
- ZA937315B ZA937315B ZA937315A ZA937315A ZA937315B ZA 937315 B ZA937315 B ZA 937315B ZA 937315 A ZA937315 A ZA 937315A ZA 937315 A ZA937315 A ZA 937315A ZA 937315 B ZA937315 B ZA 937315B
- Authority
- ZA
- South Africa
- Prior art keywords
- analgesically
- brea
- arrhythmic
- acting
- drug resistance
- Prior art date
Links
- 230000036457 multidrug resistance Effects 0.000 title abstract 2
- IJAPPYDYQCXOEF-UHFFFAOYSA-N phthalazin-1(2H)-one Chemical class C1=CC=C2C(=O)NN=CC2=C1 IJAPPYDYQCXOEF-UHFFFAOYSA-N 0.000 title abstract 2
- 230000003288 anthiarrhythmic effect Effects 0.000 title 1
- 239000003416 antiarrhythmic agent Substances 0.000 title 1
- HQFSNUYUXXPVKL-UHFFFAOYSA-N 4-[(4-fluorophenyl)methyl]-2-[1-(2-phenylethyl)azepan-4-yl]phthalazin-1-one Chemical compound C1=CC(F)=CC=C1CC(C1=CC=CC=C1C1=O)=NN1C1CCN(CCC=2C=CC=CC=2)CCC1 HQFSNUYUXXPVKL-UHFFFAOYSA-N 0.000 abstract 1
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 229960004574 azelastine Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229950006000 flezelastine Drugs 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4233113 | 1992-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA937315B true ZA937315B (en) | 1994-04-22 |
Family
ID=6469448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA937315A ZA937315B (en) | 1992-10-02 | 1993-10-01 | Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5556856A (enExample) |
| EP (1) | EP0590551B1 (enExample) |
| JP (1) | JP3623975B2 (enExample) |
| CN (1) | CN1088435A (enExample) |
| AT (1) | ATE144708T1 (enExample) |
| AU (1) | AU666773B2 (enExample) |
| CA (1) | CA2107548A1 (enExample) |
| CZ (1) | CZ199593A3 (enExample) |
| DE (1) | DE59304351D1 (enExample) |
| DK (1) | DK0590551T3 (enExample) |
| ES (1) | ES2096168T3 (enExample) |
| GR (1) | GR3022070T3 (enExample) |
| HU (1) | HUT65353A (enExample) |
| MX (1) | MX9306120A (enExample) |
| RU (1) | RU2106143C1 (enExample) |
| SK (1) | SK104493A3 (enExample) |
| UA (1) | UA26953C2 (enExample) |
| ZA (1) | ZA937315B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6162616A (en) * | 1997-04-16 | 2000-12-19 | Millennium Pharmaceuticals, Inc. | Multidrug resistance-associated polypeptide |
| US7151102B2 (en) | 2000-10-30 | 2006-12-19 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| AU2002363523A1 (en) * | 2001-11-07 | 2003-05-19 | Pharmacia Corporation | Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| JP4500161B2 (ja) | 2002-04-30 | 2010-07-14 | クドス ファーマシューティカルズ リミテッド | フタラジノン誘導体 |
| GB0305681D0 (en) | 2003-03-12 | 2003-04-16 | Kudos Pharm Ltd | Phthalazinone derivatives |
| US7449464B2 (en) | 2003-03-12 | 2008-11-11 | Kudos Pharmaceuticals Limited | Phthalazinone derivatives |
| US7294701B2 (en) * | 2003-04-02 | 2007-11-13 | Technion Research & Development Foundation Ltd. | Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| GB0419072D0 (en) | 2004-08-26 | 2004-09-29 | Kudos Pharm Ltd | Phthalazinone derivatives |
| GB0428111D0 (en) * | 2004-12-22 | 2005-01-26 | Kudos Pharm Ltd | Pthalazinone derivatives |
| GB0521373D0 (en) | 2005-10-20 | 2005-11-30 | Kudos Pharm Ltd | Pthalazinone derivatives |
| TW200811116A (en) * | 2006-04-20 | 2008-03-01 | Glaxo Group Ltd | Compounds |
| EP2041110A1 (en) * | 2006-06-15 | 2009-04-01 | Kudos Pharmaceuticals Limited | 2 -oxyheteroarylamide derivatives as parp inhibitors |
| EP2035380A2 (en) * | 2006-06-15 | 2009-03-18 | Kudos Pharmaceuticals Limited | Parp inhibitors |
| EP2041087A1 (en) * | 2006-06-15 | 2009-04-01 | Kudos Pharmaceuticals Limited | 2 -oxybenzamide derivatives as parp inhibitors |
| UY30639A1 (es) | 2006-10-17 | 2008-05-31 | Kudos Pharm Ltd | Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones |
| DE602007005167D1 (de) * | 2006-12-20 | 2010-04-15 | Glaxo Group Ltd | 4-benzyl-1(2h)-phthalazinone als h1-rezeptor-antagonisten |
| US20080280910A1 (en) * | 2007-03-22 | 2008-11-13 | Keith Allan Menear | Phthalazinone derivatives |
| TW200900396A (en) * | 2007-04-10 | 2009-01-01 | Kudos Pharm Ltd | Phthalazinone derivatives |
| US20090023727A1 (en) * | 2007-07-05 | 2009-01-22 | Muhammad Hashim Javaid | Phthalazinone derivatives |
| AU2008299721A1 (en) | 2007-09-14 | 2009-03-19 | Astrazeneca Ab | Phthalazinone derivatives |
| ATE525370T1 (de) * | 2007-10-11 | 2011-10-15 | Glaxo Group Ltd | Phthalazin- und pyridoä3,4- düpyridazinverbindungen als h1-rezeptor- antagonisten |
| CN101821242B (zh) | 2007-10-17 | 2013-07-24 | 库多斯药物有限公司 | 4-[3-(4-环丙烷羰基-哌嗪-1-羰基)-4-氟-苄基]-2h-酞嗪-1-酮 |
| AR070221A1 (es) | 2008-01-23 | 2010-03-25 | Astrazeneca Ab | Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas. |
| HUE030800T2 (en) | 2008-10-07 | 2017-05-29 | Astrazeneca Uk Ltd | Pharmaceutical Form No. 514 |
| TW201114756A (en) * | 2009-07-15 | 2011-05-01 | Astrazeneca Ab | Phthalazinone compound |
| US8937178B2 (en) | 2013-03-13 | 2015-01-20 | Flatley Discovery Lab | Phthalazinone compounds and methods for the treatment of cystic fibrosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3677322D1 (de) * | 1985-11-11 | 1991-03-07 | Asta Pharma Ag | 4-benzyl-1-(2h)-phthalazinon-derivate. |
| JPH0667844B2 (ja) * | 1987-03-06 | 1994-08-31 | エーザイ株式会社 | 虚血性心疾患の治療・予防剤 |
| US5110814A (en) * | 1989-01-11 | 1992-05-05 | Asta Pharma Ag | Azelastine and its salts used to combat psoriasis |
-
1993
- 1993-09-24 CZ CZ931995A patent/CZ199593A3/cs unknown
- 1993-09-25 EP EP93115512A patent/EP0590551B1/de not_active Expired - Lifetime
- 1993-09-25 ES ES93115512T patent/ES2096168T3/es not_active Expired - Lifetime
- 1993-09-25 DE DE59304351T patent/DE59304351D1/de not_active Expired - Lifetime
- 1993-09-25 AT AT93115512T patent/ATE144708T1/de not_active IP Right Cessation
- 1993-09-25 DK DK93115512.1T patent/DK0590551T3/da active
- 1993-09-29 CN CN93118175A patent/CN1088435A/zh active Pending
- 1993-09-30 SK SK1044-93A patent/SK104493A3/sk unknown
- 1993-09-30 UA UA93002239A patent/UA26953C2/uk unknown
- 1993-10-01 AU AU48769/93A patent/AU666773B2/en not_active Ceased
- 1993-10-01 JP JP24683493A patent/JP3623975B2/ja not_active Expired - Fee Related
- 1993-10-01 RU RU93056139A patent/RU2106143C1/ru active
- 1993-10-01 HU HU9302784A patent/HUT65353A/hu unknown
- 1993-10-01 ZA ZA937315A patent/ZA937315B/xx unknown
- 1993-10-01 CA CA002107548A patent/CA2107548A1/en not_active Abandoned
- 1993-10-01 MX MX9306120A patent/MX9306120A/es unknown
-
1995
- 1995-04-04 US US08/416,467 patent/US5556856A/en not_active Expired - Fee Related
-
1996
- 1996-12-18 GR GR960403515T patent/GR3022070T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0590551B1 (de) | 1996-10-30 |
| UA26953C2 (uk) | 1999-12-29 |
| HU9302784D0 (en) | 1993-12-28 |
| AU4876993A (en) | 1994-04-14 |
| MX9306120A (es) | 1994-04-29 |
| ES2096168T3 (es) | 1997-03-01 |
| US5556856A (en) | 1996-09-17 |
| RU2106143C1 (ru) | 1998-03-10 |
| ATE144708T1 (de) | 1996-11-15 |
| CZ199593A3 (en) | 1994-04-13 |
| DK0590551T3 (da) | 1997-04-21 |
| JP3623975B2 (ja) | 2005-02-23 |
| AU666773B2 (en) | 1996-02-22 |
| SK104493A3 (en) | 1994-08-10 |
| CA2107548A1 (en) | 1994-04-03 |
| GR3022070T3 (en) | 1997-03-31 |
| EP0590551A3 (enExample) | 1994-08-31 |
| DE59304351D1 (de) | 1996-12-05 |
| JPH06312928A (ja) | 1994-11-08 |
| CN1088435A (zh) | 1994-06-29 |
| EP0590551A2 (de) | 1994-04-06 |
| HUT65353A (en) | 1994-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA937315B (en) | Anti-arrhythmic analgesically acting phthalazinone derivatives that brea through multi-drug resistance | |
| FI954979A7 (fi) | Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset | |
| DE3778734D1 (de) | Dibenzo(b,e)oxepin-derivate sowie antiallergische und entzuendunghemmende mittel. | |
| FI891252A7 (fi) | 1,3,4,5-tetrahydrobenz /c,d/ indol. | |
| NO891191D0 (no) | Fremgangsmaate for fremstilling av nye, terapeutisk virksomme catecholderivater. | |
| NO894539L (no) | Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater. | |
| DE68923131D1 (de) | Bohrer, Schleifverfahren und Schleifvorrichtung. | |
| FI890520L (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2- (piperidin-4-ylmetyl) -1,2,3,4 -tetrahydroisokinolinderivat. | |
| IT1230795B (it) | Procedimento per preparare 1,1,1,2 tetrafluoroetano da 1,1 dicloro 1,2,2,2 tetrafluoroetano. | |
| DE58907381D1 (de) | Ungesättigte Derivate von 2,2,6,6-Tetramethylpiperidin. | |
| ITGE930024A0 (it) | Gruppo elettrochirurgico trequarti,cosiddetto "trocar", con elettrodi bipolari. | |
| DK0935598T3 (da) | 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet | |
| ES2099865T3 (es) | Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares. | |
| DE3584652D1 (de) | 2,2,6,6-tetramethyl-4-piperidinyl-derivate und ihre verwendung als lichtstabilisatoren. | |
| FI944655L (fi) | Uudet 2,3-dihydro-2,2,4,6,7-penta-alkyyli-5-bentsofuranolit | |
| NO894038L (no) | Fremgangsmaate for fremstilling av nye 2-karbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner. | |
| FI890864L (fi) | Anvaendning av 1,4-dihydropyridinderivat. | |
| NO891025L (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktivesialosylglycerider. | |
| NO894516D0 (no) | Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter. | |
| IT8403443A0 (it) | Procedimento per la stiratura dellatomaia dei mocassini,e dispositivoper l'attuazione del procedimento | |
| FI933872A7 (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat | |
| NO894037D0 (no) | Fremgangsmaate for fremstilling av nye 2-metoksykarbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner. | |
| ITPS910013A1 (it) | Testa multipla per foratrici, con attivazione esclusiva dei mandrini effettivamente utilizzati. | |
| ITPE910039V0 (it) | Testa multipla per foratrici, con attivazione esclusiva dei mandrini effetivamente utilizzati | |
| ITPS910039V0 (it) | Testa multipla per foratrici, con attivazione esclusiva dei mandrini effetivamente utilizzati |